A new Alzheimer’s drug brings hope, controversy

The FDA’s recent approval of a new drug, Aduhelm, to clear the formation of amyloid plaques in the brain is potentially good news for the six million Americans who suffer from Alzheimer’s disease. But the approval process for Aduhelm has stirred controversy. Correspondent Susan Spencer talks with experts about the clinical benefits of this new class of drugs; and with early-onset Alzheimer’s patients, including a former neurologist who enrolled in an early trial of Aduhelm.

“CBS Sunday Morning” features stories on the arts, music, nature, entertainment, sports, history, science and Americana, and highlights unique human accomplishments and achievements. Check local listings for CBS Sunday Morning broadcast times.

Subscribe to the “CBS Sunday Morning” YouTube channel: http://bit.ly/20gXwJT
Get more of “CBS Sunday Morning”: http://cbsn.ws/1PlMmAz
Follow “CBS Sunday Morning” on Instagram: http://bit.ly/23XunIh
Like “CBS Sunday Morning” on Facebook: https://bit.ly/3sRgLPG
Follow “CBS Sunday Morning” on Twitter: http://bit.ly/1RquoQb
Subscribe to our newsletter: http://cbsn.ws/1RqHw7T
Download the CBS News app: http://cbsn.ws/1Xb1WC8
Try Paramount+ free: https://bit.ly/2OiW1kZ

For video licensing inquiries, contact: licensing@veritone.com